Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about INCY
Recent news which mentions INCY
< Previous
1
2
3
4
5
6
7
8
Next >
Novartis Agrees To Acquire German Blood Cancer-Drug Developer MorphoSys For €2.7B
February 06, 2024
Tickers
INCY
MOR
NEWS
NVS
Tags
Market News
Benzinga
Trading Ideas
From
Benzinga
Why Is MorphoSys (MOR) Stock Up 50% Today?
February 05, 2024
Tickers
INCY
MOR
NVS
Tags
NVS
Today's Market
INCY
From
InvestorPlace
MorphoSys Stock Soars After Report Says Novartis To Acquire Cancer-Drug Developer
February 05, 2024
Tickers
INCY
MOR
NEWS
NVS
Tags
NVS
Movers & Shakers
News
From
Benzinga
3 Pharma Stocks Could Be the Pills Your Portfolio Needs
January 18, 2024
Tickers
EXEL
INCY
PFE
SGEN
Tags
NYSE:PFE,NASDAQ:SGEN,NASDAQ:INCY,NASDAQ:EXEL
INCY
EXEL
From
InvestorPlace
Analyst Highlights Aclaris Therapeutics' Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations
January 10, 2024
Tickers
ACRS
INCY
NEWS
ROIV
Tags
Benzinga
Penny Stocks
Market News
From
Benzinga
AI Meets Biotech: 3 Top Stocks Transforming Medical Science
December 16, 2023
Tickers
ABCL
BAYRY
DNA
GOOG
Tags
GOOGL
DNA
BAYRY
From
InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in December
December 15, 2023
Tickers
INCY
KNSA
NBIX
RHHBY
Tags
Stocks to Buy
NASDAQ:KNSA,OTCMKTS:RHHBY,NASDAQ:NBIX,NASDAQ:INCY
Market News
From
InvestorPlace
Expert Ratings for Incyte
December 13, 2023
Tickers
INCY
Tags
BZI/AAR
Benzinga
Market News
From
Benzinga
What's Up With Incyte Stock Lately?
December 12, 2023
Tickers
INCY
Tags
News
why it's moving
INCY
From
Benzinga
S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets
December 07, 2023
Tickers
ALB
ALGN
ALK
APA
Tags
Trading Ideas
BWA
UAL
From
Benzinga
Goldman Sachs Downgrades Incyte Amid Concerns Over Jakafi Studies, Competitiveness
November 21, 2023
Tickers
INCY
Tags
Biotech
Large Cap
Equities
From
Benzinga
The Latest Analyst Ratings for Incyte
November 21, 2023
Tickers
INCY
Tags
Market News
Analyst Ratings
INCY
From
Benzinga
3 Biotech Stocks That Are Poised to Have Breakthroughs in 2024
November 12, 2023
Tickers
CRSP
INCY
SWAV
Tags
SWAV
Market News
Stocks to Buy
From
InvestorPlace
7 Underappreciated Biotech Stocks to Pick Up on the Cheap
November 09, 2023
Tickers
BNTX
CORT
GMAB
HALO
Tags
KNSA
GMAB
NASDAQ:REGN,NASDAQ:BNTX,NYSE:PFE,NASDAQ:HALO,NASDAQ:CORT,NASDAQ:INCY,NASDAQ:GMAB,NASDAQ:KNSA
From
InvestorPlace
Goldman Sachs Maintains Buy Rating for Incyte: Here's What You Need To Know
November 02, 2023
Tickers
INCY
Tags
INCY
Analyst Ratings
Market News
From
Benzinga
Earnings Outlook For Incyte
October 30, 2023
Tickers
INCY
Tags
Earnings
Market News
INCY
From
Benzinga
Quant Ratings Updated on 73 Stocks
September 26, 2023
Tickers
ABT
AWK
CL
CNI
Tags
AWK
Market News
GIS
From
InvestorPlace
Expert Ratings for Incyte
September 21, 2023
Tickers
INCY
Tags
Benzinga
BZI/AAR
INCY
From
Benzinga
3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall
September 20, 2023
Tickers
EXEL
INCY
JAZZ
Tags
Stocks to Buy
NASDAQ:JAZZ,NASDAQ:INCY,NASDAQ:EXEL
INCY
From
InvestorPlace
Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison
September 18, 2023
Tickers
BMY
GSK
INCY
Tags
Analyst Color
Markets
Expert Ideas
From
Benzinga
Analyst Ratings for Incyte
August 02, 2023
Tickers
INCY
Tags
BZI/AAR
Benzinga
Analyst Ratings
From
Benzinga
Incyte's Jakafi Patent Expiry In 2028 Poses Challenge, Analyst Says New Treatments To Battle For Market Share
August 01, 2023
Tickers
INCY
Tags
INCY
Briefs
News
From
Benzinga
Incyte's Earnings Outlook
July 31, 2023
Tickers
INCY
Tags
Benzinga
Earnings
Market News
From
Benzinga
Cathie Wood's Ark Invest Buys Spotify, Iridium Shares — Trims Tesla, Coinbase Holdings
July 25, 2023
Tickers
ACCD
AIR
ARKQ
ARKW
Tags
ARK Investment Management
Tesla
Iridium Communications
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2023
July 25, 2023
Tickers
ABBV
AGLE
AI
AVNS
Tags
X
DDOG
Initiation
From
Benzinga
Syndax-Incyte Partnered Chronic Graft-Versus-Host Disease Achieves Primary Endpoint In Pivotal Trial, FDA Submission Planned By 2023 End
July 24, 2023
Tickers
INCY
SNDX
Tags
Market News
Benzinga
Biotech
From
Benzinga
'I Don't Want You To Touch That': Cramer Rejects Stock Down 32% Over Past Month, Prefers Tesla
July 19, 2023
Tickers
ARE
ASTS
CNC
FRT
Tags
Penny Stocks
Trading Ideas
mad money Lightning Round
From
Benzinga
Incyte Skin Disease Drug Meets Primary Goal In Late-Stage Study In Children
July 12, 2023
Tickers
INCY
Tags
Market News
Benzinga
Briefs
From
Benzinga
Syndax Pharmaceuticals Set for Potential Breakthrough with Revumenib: Analyst Calls It 'Potentially Best-In-Class' In Competitive Landscape
July 11, 2023
Tickers
INCY
SNDX
Tags
Biotech
Small Cap
Health Care
From
Benzinga
2 Low-Priced Stocks That Could Make You Richer
June 26, 2023
Tickers
ACRS
AGEN
AXSM
BMY
Tags
VKTX
AGEN
AXSM
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.